Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
0.8599
Dollar change
-0.0301
Percentage change
-3.38
%
Index- P/E- EPS (ttm)-1.20 Insider Own31.09% Shs Outstand16.28M Perf Week14.67%
Market Cap15.74M Forward P/E- EPS next Y-0.53 Insider Trans0.17% Shs Float11.48M Perf Month-4.46%
Income-14.79M PEG- EPS next Q-0.21 Inst Own13.65% Short Float4.50% Perf Quarter-12.26%
Sales8.96M P/S1.76 EPS this Y37.31% Inst Trans199.14% Short Ratio5.24 Perf Half Y-65.74%
Book/sh-0.15 P/B- EPS next Y52.90% ROA-220.48% Short Interest0.52M Perf Year-72.96%
Cash/sh0.12 P/C7.39 EPS next 5Y- ROE-701.30% 52W Range0.67 - 5.65 Perf YTD-78.92%
Dividend Est.- P/FCF- EPS past 5Y5.77% ROI- 52W High-84.78% Beta1.39
Dividend TTM- Quick Ratio0.70 Sales past 5Y25.92% Gross Margin58.12% 52W Low28.75% ATR (14)0.09
Dividend Ex-DateJul 07, 2017 Current Ratio0.75 EPS Y/Y TTM92.31% Oper. Margin-189.47% RSI (14)55.73 Volatility11.60% 10.85%
Employees64 Debt/Eq- Sales Y/Y TTM-2.33% Profit Margin-165.07% Recom2.33 Target Price4.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q52.18% Payout- Rel Volume0.95 Prev Close0.89
Sales Surprise-17.30% EPS Surprise0.97% Sales Q/Q1.80% EarningsNov 14 BMO Avg Volume98.54K Price0.86
SMA206.91% SMA502.86% SMA200-55.36% Trades Volume93,859 Change-3.38%
Date Action Analyst Rating Change Price Target Change
Jan-12-22Resumed Cantor Fitzgerald Overweight $4
Mar-29-21Initiated Truist Buy $12
Jan-29-21Initiated Cantor Fitzgerald Overweight $10
Oct-30-20Initiated William Blair Outperform
Nov-15-24 02:08AM
Nov-14-24 08:00AM
Nov-13-24 07:34AM
Nov-07-24 08:00AM
Nov-04-24 08:00AM
08:00AM Loading…
Oct-25-24 08:00AM
Oct-23-24 11:23AM
Oct-15-24 04:05PM
Sep-10-24 08:00AM
Sep-06-24 08:00AM
Sep-05-24 08:00AM
Aug-27-24 08:00AM
Aug-12-24 04:05PM
Aug-05-24 08:37AM
Aug-01-24 08:00AM
04:05PM Loading…
Jul-31-24 04:05PM
Jul-29-24 09:00AM
Jul-11-24 08:00AM
Jul-09-24 12:12PM
Jul-01-24 05:24PM
Jun-13-24 08:00AM
May-16-24 08:00AM
May-15-24 11:53AM
08:40AM
07:30AM
May-08-24 08:47AM
08:00AM
May-07-24 08:00AM
May-02-24 08:00AM
Apr-09-24 08:00AM
11:24AM Loading…
Apr-01-24 11:24AM
Mar-28-24 11:53AM
07:30AM
Mar-25-24 08:00AM
Mar-21-24 08:00AM
Mar-18-24 08:00AM
Mar-11-24 08:00AM
Feb-22-24 08:30AM
Feb-12-24 08:00AM
Feb-06-24 08:00AM
Jan-25-24 08:00AM
07:30AM
Dec-19-23 08:00AM
Dec-14-23 08:00AM
Dec-08-23 09:46AM
Dec-07-23 09:20AM
Dec-06-23 08:00AM
Nov-28-23 08:00AM
Nov-27-23 09:47AM
Nov-13-23 04:05PM
Nov-09-23 08:00AM
Oct-31-23 08:00AM
Oct-25-23 08:00AM
Oct-23-23 08:00AM
Oct-20-23 10:43AM
Sep-29-23 08:00AM
Sep-13-23 08:00AM
Sep-11-23 08:00AM
Aug-31-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-14-23 04:01PM
Aug-09-23 04:05PM
Jul-31-23 08:00AM
Jul-20-23 08:30AM
Jun-28-23 08:00AM
Jun-12-23 06:23PM
Jun-08-23 01:23PM
01:23PM
Jun-05-23 08:00AM
Jun-02-23 09:35AM
08:00AM
May-31-23 08:00AM
May-30-23 08:00AM
May-26-23 09:15AM
May-19-23 09:38AM
08:00AM
May-16-23 04:05PM
May-15-23 04:05PM
09:00AM
May-11-23 04:01PM
12:33PM
09:45AM
08:00AM
May-09-23 04:07PM
Apr-27-23 04:05PM
Mar-27-23 07:12AM
Mar-22-23 04:05PM
Mar-03-23 08:38AM
08:00AM
Jan-09-23 04:05PM
Jan-06-23 08:00AM
Dec-27-22 08:00AM
Nov-29-22 04:01PM
Nov-10-22 07:00AM
Nov-01-22 08:00AM
Oct-06-22 04:05PM
Oct-05-22 08:00AM
Sep-27-22 09:05AM
Sep-12-22 04:28PM
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vos Ellen O'ConnorDirectorSep 30 '24Option Exercise0.005,313058,052Oct 03 04:44 PM
Cavanaugh Stefanie L.DirectorSep 30 '24Option Exercise0.005,938060,914Oct 02 06:05 PM
Parnell WinfredDirectorSep 30 '24Option Exercise0.005,156055,740Oct 02 05:55 PM
Herchuk Jannie PrestridgeDirectorSep 30 '24Option Exercise0.008,438057,190Oct 02 05:39 PM
Ragard John PhillipDirectorSep 30 '24Option Exercise0.004,8440120,203Oct 02 05:31 PM
Fralick Celeste RachelleDirectorSep 30 '24Option Exercise0.005,000045,665Oct 02 05:19 PM
Sandford NicoleChief Executive OfficerMay 31 '24Buy2.429,49322,97370,596Jun 03 05:30 PM
Merchant Minh HoangSecretary & General CounselDec 06 '23Sale3.379803,3030Dec 08 05:28 PM
Sandford NicolePresident & CEODec 06 '23Buy3.365,00016,80058,703Dec 06 05:21 PM